Supplemental material
Journal of Biomolecular Structure and Dynamics
Volume 40, 2022 - Issue 22
Research Articles
FMS-like tyrosine kinase-3 (FLT3) inhibitors with better binding affinity and ADMET properties than sorafenib and gilteritinib against acute myeloid leukemia: in silico studies
Chukwuebuka Egbunaa Africa Centre of Excellence in Public Health and Toxicological Research (ACE-PUTOR), University of Port-Harcourt, Port Harcourt, Rivers State, Nigeria;b Department of Biochemistry, Faculty of Science, University of Port Harcourt, Port Harcourt, Rivers State, Nigeria;c Department of Biochemistry, Faculty of Natural Sciences, Chukwuemeka Odumegwu Ojukwu University, Uli, Anambra State, NigeriaCorrespondence[email protected] [email protected]
https://orcid.org/0000-0001-8382-0693View further author information
https://orcid.org/0000-0001-8382-0693View further author information, , , Johra Khand Department of Medical Laboratory Sciences, College of Applied Medical Sciences, Majmaah University, Majmaah, Saudia Arabia;e Health and Basic Sciences Research Center, Majmaah University, Majmaah, Saudi Arabiahttps://orcid.org/0000-0002-0044-4758View further author information
https://orcid.org/0000-0002-0044-4758View further author information &